EUVIMEDObjevte EUVIMED
Open access

Cuproptosis-related gene DLAT serves as a prognostic biomarker for immunotherapy in clear cell renal cell carcinoma: multi-database and experimental verification

Shuaishuai Huang, Congbo Cai, Kena Zhou, Xue Wang, Xue Wang, Dong Cen, Guobin Weng

Aging · 2023

DOI: 10.18632/aging.205181 ↗

At a glance

Journal article in Aging, 2023. Written by Shuaishuai Huang and 6 co-authors. Institution: Department of Laboratory, Ningbo Urology and Nephrology Hospital, Ningbo, China. Major MEDLINE topics: Carcinoma, Carcinoma, Renal Cell, Kidney Neoplasms, Apoptosis. Cited 13 times so far (Crossref); 31 references. The full text is freely available in PubMed Central.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

OBJECTIVE: Renal clear cell carcinoma (ccRCC) is the most common type of renal cancer. Here we aim to explore the prognosis and immunotherapeutic value of copper death-related gene Dihydrolipoamide S-acetyltransferase (DLAT) in ccRCC. METHODS: The mRNA and protein expressions and methylation level of DLAT, as well as the relation of DLAT to survival prognosis, clinical characteristics, biological function, and immune microenvironment and responses in patients with ccRCC were evaluated using multiple databases. In addition, 75 paired ccRCC tissue samples and 3 kinds of cell lines were tested for experimental validation. RESULTS: Bioinformatics analysis of multiple databases, qRT-PCR, and western blot verified that DLAT expression in ccRCC was lower than that in paracancerous tissues. Patients with low expression of DLAT had a lower survival rate, worse clinical prognosis, stronger immune cell infiltration and expression of immunosuppressive points, and higher tumor immune dysfunction and exclusion (TIDE) scores. CONCLUSIONS: DLAT was identified as an independent prognostic factor in ccRCC and was closely related to the prognosis and immune responses of patients with ccRCC.

Subjects

MeSH terms (MEDLINE)

CarcinomaCarcinoma, Renal CellKidney NeoplasmsApoptosisHumansBiomarkersDihydrolipoyllysine-Residue AcetyltransferaseImmunotherapyPrognosisTumor MicroenvironmentCopper

Author keywords

DLATclear cell renal cell carcinomaimmune responseprognosistumor microenvironment

Substances

BiomarkersDihydrolipoyllysine-Residue AcetyltransferaseCopper

Authors and institutions

  • Department of Laboratory, Ningbo Urology and Nephrology Hospital, Ningbo, China.
  • Department of Emergency, Ningbo Urology and Nephrology Hospital, Ningbo, China.
  • Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Ultrasound, Ningbo Urology and Nephrology Hospital, Ningbo, China.

Cite

APA

Huang, S., Cai, C., Zhou, K., Wang, X., Wang, X., Cen, D., & Weng, G. (2023). Cuproptosis-related gene DLAT serves as a prognostic biomarker for immunotherapy in clear cell renal cell carcinoma: multi-database and experimental verification. Aging. https://doi.org/10.18632/aging.205181

Vancouver

Huang S, Cai C, Zhou K, Wang X, Wang X, Cen D, et al. Cuproptosis-related gene DLAT serves as a prognostic biomarker for immunotherapy in clear cell renal cell carcinoma: multi-database and experimental verification. Aging. 2023. doi:10.18632/aging.205181

BibTeX
@article{Huang2023,
  author = {Huang, Shuaishuai and Cai, Congbo and Zhou, Kena and Wang, Xue and Wang, Xue and Cen, Dong and Weng, Guobin},
  title = {Cuproptosis-related gene DLAT serves as a prognostic biomarker for immunotherapy in clear cell renal cell carcinoma: multi-database and experimental verification},
  journal = {Aging},
  year = {2023},
  doi = {10.18632/aging.205181}
}
Start for free →